We are live on ! Find out more
VERV

Verve Therapeutics
VERV

Delisted

VERV was delisted on the 24th of July, 2025.

Back to rankings

Fund managers haven’t disclosed any holdings of VERV yet.

VERV Hedge Fund Activity: Q1 2026 in Review

0 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Verve Therapeutics (VERV) for Q1 2026, worth a combined $0 — down 100% from $344K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of VERV and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest seller was DekaBank Deutsche Girozentrale, exiting entirely with an estimated $344K sold.

  • 0 institutional investors held Verve Therapeutics (VERV) as of Q1 2026, down from 1 in Q4 2025.
  • Funds reported $0 of Verve Therapeutics stock for Q1 2026, down 100% quarter-over-quarter.
  • 0 funds opened new Verve Therapeutics positions in Q1 2026 and 1 closed out, a net change of -1 holder.
  • The largest Verve Therapeutics seller in Q1 2026 was DekaBank Deutsche Girozentrale, an estimated $344K sold.

Based on aggregated 13F filings for Q1 2026.